Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation.

McIlroy G, Nikolousis E, Abou-Zeid N, Shankara P, Kishore B, Kaparou M, Lovell R, Elmoamly S, Davies D, Horgan C, Shenouda A, Kanellopoulos A.

Leuk Lymphoma. 2019 Aug 11:1-4. doi: 10.1080/10428194.2019.1650177. [Epub ahead of print] No abstract available.


Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease.

Kinsella FAM, Inman CF, Gudger A, Chan YT, Murray DJ, Zuo J, McIlroy G, Nagra S, Nunnick J, Holder K, Wall K, Griffiths M, Craddock C, Nikolousis E, Moss P, Malladi R.

Leuk Res. 2019 Aug;83:106173. doi: 10.1016/j.leukres.2019.106173. Epub 2019 Jun 18.


Moving cancer care closer to home: a single-centre experience of home chemotherapy administration for patients with myelodysplastic syndrome.

Murthy V, Wilson J, Suhr J, James L, Tombs H, Shereef E, Nikolousis E.

ESMO Open. 2019 Mar 30;4(2):e000434. doi: 10.1136/esmoopen-2018-000434. eCollection 2019. No abstract available.


Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience.

Horgan C, Elmoamly S, McIlroy G, Davies D, Kaparou M, Giles H, Xenou E, Kishore B, Lovell R, Nikolousis E, Shankara P, Kanellopoulos A.

Leuk Lymphoma. 2019 May 13:1-3. doi: 10.1080/10428194.2019.1607323. [Epub ahead of print] No abstract available.


Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia.

Kanellopoulos A, Kaparou M, Xenou E, Paneesha S, Kishore B, Lovell R, Holder K, Suhr J, Baker L, Ryan L, Nikolousis E.

Bone Marrow Transplant. 2018 Dec;53(12):1518-1521. doi: 10.1038/s41409-018-0297-z. Epub 2018 Aug 16.


Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant.

Randall K, Kaparou M, Xenou E, Paneesha S, Kishore B, Kanellopoulos A, Lovell R, Holder K, Suhr J, Baker L, Ryan L, Nikolousis E.

Eur J Haematol. 2017 Oct;99(4):300-305. doi: 10.1111/ejh.12917. Epub 2017 Jul 20.


Sclerosing angiomatoid nodular transformation of the spleen.

Murthy V, Miller B, Nikolousis EM, Pratt G, Rudzki Z.

Clin Case Rep. 2015 Oct;3(10):888-90. doi: 10.1002/ccr3.325. Epub 2015 Sep 10.


Intestinal lymphoma--a review of the management of emergency presentations to the general surgeon.

Abbott S, Nikolousis E, Badger I.

Int J Colorectal Dis. 2015 Feb;30(2):151-7. doi: 10.1007/s00384-014-2061-1. Epub 2014 Nov 6. Review.


Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study.

Nikolousis E, Nagra S, Pearce R, Perry J, Kirkland K, Byrne J, Dignan F, Tholouli E, Gilleece M, Russell N, Littlewood T, Cook M, Peniket A, Shaw BE, Cook G, Craddock C.

Bone Marrow Transplant. 2015 Jan;50(1):82-6. doi: 10.1038/bmt.2014.215. Epub 2014 Oct 6.


Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm.

Lokare A, Nikolousis E, Phillips N, Rudzki Z, Lovell R, Kishore B, Milligan D, Paneesha S.

Hematol Rep. 2014 Jan 29;6(1):5119. doi: 10.4081/hr.2014.5119. eCollection 2014 Jan 29.


Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant.

Nikolousis E, Robinson S, Nagra S, Brookes C, Kinsella F, Tauro S, Jeffries S, Griffiths M, Mahendra P, Cook M, Paneesha S, Lovell R, Kishore B, Chaganti S, Malladi R, Raghavan M, Moss P, Milligan D, Craddock C.

Leuk Res. 2013 May;37(5):561-5. doi: 10.1016/j.leukres.2013.01.010. Epub 2013 Feb 5.


Two cases of aspergillus endocarditis in non neutropenic children on chemotherapy for acute lymphoblastic leukaemia.

Nikolousis E, Velangi M.

Hematol Rep. 2011 Jan 13;3(1):e7. doi: 10.4081/hr.2011.e7. Epub 2011 Jun 30.


Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies.

Nikolousis E, Nagra S, Paneesha S, Delgado J, Holder K, Bratby L, Chaganti S, Lovell R, Milligan D.

Ann Hematol. 2010 Nov;89(11):1141-5. doi: 10.1007/s00277-010-1001-6. Epub 2010 Jun 11.


Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.

Craddock C, Nagra S, Peniket A, Brookes C, Buckley L, Nikolousis E, Duncan N, Tauro S, Yin J, Liakopoulou E, Kottaridis P, Snowden J, Milligan D, Cook G, Tholouli E, Littlewood T, Peggs K, Vyas P, Clark F, Cook M, Mackinnon S, Russell N.

Haematologica. 2010 Jun;95(6):989-95. doi: 10.3324/haematol.2009.013920. Epub 2009 Nov 30.


Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes.

Goardon N, Nikolousis E, Sternberg A, Chu WK, Craddock C, Richardson P, Benson R, Drayson M, Standen G, Vyas P, Freeman S.

Haematologica. 2009 Aug;94(8):1160-3. doi: 10.3324/haematol.2008.004085.


Midazolam in conjunction with local anaesthesia is superior to Entonox in providing pain relief during bone marrow aspirate and trephine biopsy.

Chakupurakal G, Delgado J, Nikolousis E, Pitchapillai S, Allotey D, Holder K, Bratby L, de la Rue J, Milligan DW.

J Clin Pathol. 2008 Sep;61(9):1051-4. doi: 10.1136/jcp.2008.058180.


Philadelphia-positive chronic-phase chronic myeloid leukaemia after long-term remission of Philadelphia-negative acute lymphoblastic leukaemia.

Nikolousis E, Revell P, Novitzky-Basso I, Amos A.

Acta Haematol. 2008;119(2):124-5. doi: 10.1159/000125191. Epub 2008 Apr 8. No abstract available.


Supplemental Content

Loading ...
Support Center